Jason Gerberry
Stock Analyst at B of A Securities
(4.21)
# 394
Out of 5,173 analysts
163
Total ratings
61.16%
Success rate
10.01%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $263 → $275 | $182.32 | +50.83% | 7 | Feb 25, 2026 | |
| HRMY Harmony Biosciences Holdings | Maintains: Underperform | $32 → $28 | $27.60 | +1.45% | 3 | Feb 25, 2026 | |
| ALKS Alkermes | Maintains: Neutral | $33 → $34 | $27.71 | +22.70% | 10 | Feb 20, 2026 | |
| PFE Pfizer | Maintains: Neutral | $29 → $28 | $26.77 | +4.59% | 5 | Dec 15, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $62 → $81 | $56.67 | +42.93% | 4 | Dec 9, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $86 → $97 | $70.79 | +37.03% | 7 | Dec 9, 2025 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $29 → $32 | $28.77 | +11.23% | 15 | Dec 9, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $30 → $29 | $24.60 | +17.89% | 4 | Nov 13, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Neutral | $28 → $32 | $19.23 | +66.41% | 2 | Aug 26, 2025 | |
| IMVT Immunovant | Maintains: Buy | $33 → $30 | $24.38 | +23.05% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $49 | $8.74 | +460.64% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $173 → $176 | $156.84 | +12.22% | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 → $1 | $1.94 | -48.45% | 4 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $23 | $35.50 | -35.21% | 2 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $46 | $41.41 | +11.08% | 3 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $137 | $55.94 | +144.91% | 9 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $11 → $10 | $13.29 | -24.76% | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $23.32 | +28.64% | 2 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $100 | $114.60 | -12.74% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $24 | $9.82 | +144.40% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $41 → $31 | $31.90 | -2.82% | 6 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $56 | $54.42 | +2.90% | 2 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $450 → $500 | $910.55 | -45.09% | 15 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 | $2.44 | +268.85% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $37 → $25 | $6.09 | +310.51% | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $5 | $1.65 | +203.03% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $27 | $5.10 | +429.41% | 4 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $1.64 | +1,119.51% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $100 | $4.85 | +1,961.86% | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $95 | $204.93 | -53.64% | 10 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $57.00 | +5.26% | 7 | Oct 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $90 | $115.68 | -22.20% | 11 | Oct 17, 2019 |
Jazz Pharmaceuticals
Feb 25, 2026
Maintains: Buy
Price Target: $263 → $275
Current: $182.32
Upside: +50.83%
Harmony Biosciences Holdings
Feb 25, 2026
Maintains: Underperform
Price Target: $32 → $28
Current: $27.60
Upside: +1.45%
Alkermes
Feb 20, 2026
Maintains: Neutral
Price Target: $33 → $34
Current: $27.71
Upside: +22.70%
Pfizer
Dec 15, 2025
Maintains: Neutral
Price Target: $29 → $28
Current: $26.77
Upside: +4.59%
Arrowhead Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $62 → $81
Current: $56.67
Upside: +42.93%
Ionis Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $86 → $97
Current: $70.79
Upside: +37.03%
Teva Pharmaceutical Industries
Dec 9, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $28.77
Upside: +11.23%
Oculis Holding AG
Nov 13, 2025
Maintains: Buy
Price Target: $30 → $29
Current: $24.60
Upside: +17.89%
Amphastar Pharmaceuticals
Aug 26, 2025
Maintains: Neutral
Price Target: $28 → $32
Current: $19.23
Upside: +66.41%
Immunovant
Aug 12, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $24.38
Upside: +23.05%
Aug 12, 2025
Maintains: Buy
Price Target: $50 → $49
Current: $8.74
Upside: +460.64%
Aug 5, 2025
Maintains: Buy
Price Target: $173 → $176
Current: $156.84
Upside: +12.22%
Jun 30, 2025
Downgrades: Underperform
Price Target: $3 → $1
Current: $1.94
Upside: -48.45%
Jun 11, 2025
Maintains: Buy
Price Target: $25 → $23
Current: $35.50
Upside: -35.21%
Jun 5, 2025
Maintains: Neutral
Price Target: $45 → $46
Current: $41.41
Upside: +11.08%
Apr 1, 2025
Maintains: Buy
Price Target: $157 → $137
Current: $55.94
Upside: +144.91%
Feb 28, 2025
Maintains: Underperform
Price Target: $11 → $10
Current: $13.29
Upside: -24.76%
Jan 9, 2025
Reiterates: Buy
Price Target: $30
Current: $23.32
Upside: +28.64%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $100
Current: $114.60
Upside: -12.74%
Sep 10, 2024
Maintains: Buy
Price Target: $20 → $24
Current: $9.82
Upside: +144.40%
Apr 1, 2024
Downgrades: Underperform
Price Target: $41 → $31
Current: $31.90
Upside: -2.82%
Jan 2, 2024
Maintains: Buy
Price Target: $52 → $56
Current: $54.42
Upside: +2.90%
May 24, 2023
Maintains: Buy
Price Target: $450 → $500
Current: $910.55
Upside: -45.09%
Dec 12, 2022
Downgrades: Underperform
Price Target: $9
Current: $2.44
Upside: +268.85%
Oct 14, 2022
Downgrades: Underperform
Price Target: $37 → $25
Current: $6.09
Upside: +310.51%
Dec 2, 2021
Downgrades: Underperform
Price Target: $45 → $5
Current: $1.65
Upside: +203.03%
Mar 24, 2021
Downgrades: Underperform
Price Target: $27
Current: $5.10
Upside: +429.41%
Jul 16, 2020
Initiates: Neutral
Price Target: $20
Current: $1.64
Upside: +1,119.51%
Jul 15, 2020
Downgrades: Neutral
Price Target: $170 → $100
Current: $4.85
Upside: +1,961.86%
May 18, 2020
Reinstates: Neutral
Price Target: $95
Current: $204.93
Upside: -53.64%
Oct 17, 2019
Reinstates: Buy
Price Target: $60
Current: $57.00
Upside: +5.26%
Oct 17, 2019
Reinstates: Neutral
Price Target: $90
Current: $115.68
Upside: -22.20%